CHPG is a selective mGluR5 agonist that reduces LDH release and neuronal apoptosis, activates the ERK and Akt pathways, and protects against traumatic brain injury. It also increases the number of differentiated human OPCs and alleviates LPS-induced inflammation.
Molekulargewicht:
201.61
CAS Nummer:
[170846-74-9]
Formel:
C8H8ClNO3
Target-Kategorie:
Akt|||GluR|||NF-kappaB|||Dehydrogenase|||ERK
T10809
T10809
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
